RecruitingNCT04655066

Evaluation of the Subjectively Perceived Pelvic Floor Function in Patients With Gynecological Tumors and Breast Cancer Under Systemic Tumor Therapy Using a Validated Questionnaire

PANTHERA-Studie "Pelvic Floor Disorders in Patients Under ANtineoplastic THERApy"


Sponsor

St. Josefs-Hospital Wiesbaden GmbH

Enrollment

200 participants

Start Date

Apr 1, 2018

Study Type

OBSERVATIONAL

Conditions

Summary

The multimodal therapy of gynecological malignancies and breast cancer often leads to an impairment of the pelvic floor function. This has a major impact on the quality of life of cancer patients. The aim of the study is to record and analyze the potential subjective impairment of the bladder, bowel and sexual function under systemic tumor therapy as well as possible influencing factors by means of validated disease-specific questionnaires. to find possible starting points for the prevention and treatment of the symptoms.


Eligibility

Min Age: 18 Years

Inclusion Criteria2

  • Breastcancer under tumor therapy
  • Gynecological carcinoma under tumor therapy

Exclusion Criteria1

  • none

Locations(1)

St. Josefs-Hospital Wiesbaden GmbH

Wiesbaden, Germany

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04655066


Related Trials